This invention generally relates to a combination therapy comprising the use of a substituted benzoimidazole compound and a nonsteroidal anti-inflammatory drug (NSAID) or acetaminophen, and, in particular, to the use of methyl 2-((2-(2,6-difluoro-4- (methylcarbamoyl)phenyl)-5-methyl-1H-benzo[d]imidazol-1-yl)methyl)morpholine-4- carboxylate or a salt thereof and an NSAID or acetaminophen to treat pain. This invention also relates to the combinations themselves, uses of such a combination, and pharmaceutical compositions and kits comprising such a combination.
展开▼